Cardiac Resynchronization Therapy Devices (CRT)

Cardiac Resynchronization Therapy Devices (CRT) are cardiac electrophysiology (EP) systems that include a small electronic device that is surgically implanted into a pocket of skin to help both ventricles contract together. They are also called biventricular pacemakers. These systems can be used for pacing only, or can include a built-in defibrillator.

Videos | EP Lab

Khaldoun Tarakji, M.D., MPH, associate section head, cardiac electrophysiology, Heart and Vascular Institute at ...

Home October 04, 2021
Home
News | Atrial Fibrillation

September 13, 2021 — Ablation plus cardiac resynchronization therapy (CRT) is superior to pharmacological rate control ...

Home September 13, 2021
Home
News | Cardiac Resynchronization Therapy Devices (CRT)

August 3, 2021 — In association with Heart Rhythm 2021, Biotronik announced first enrollments in the landmark BIO ...

Home August 03, 2021
Home
Videos | EP Lab

Samir Saba, M.D., co-director of the University of Pittsburgh Medical Center Heart and Vascular Institute, and chief ...

Home August 02, 2021
Home
News | EP Lab

July 28, 2021 — The U.S. Justice Department announced earlier this month that St. Jude Medical Inc. agreed to pay $27 ...

Home July 28, 2021
Home
News | EP Lab

July 27, 2021 — Medtronic announced new data from the landmark WRAP-IT study published in Heart Rhythm,[1] demonstrating ...

Home July 27, 2021
Home
News | EP Lab

June 2, 2021 — Implicity, a leader in remote patient monitoring software and cardiac data management solutions ...

Home June 02, 2021
Home
News | EP Lab

May 14, 2021 — The U.S. Food and Drug Administration (FDA) is advising patients and caregivers to keep any consumer ...

Home May 14, 2021
Home
News | EP Lab

May 6, 2021 - Bluegrass Vascular Technologies announced the publication of a report documenting the clinical utility of ...

Home May 06, 2021
Home
Medtronic is recalling some of its implantable cardioverter defibrillators (ICD) and cardiac resynchronization therapy (CRT-D) devices because of an unexpected and rapid decrease in battery life. The company said this is due to a short circuit and will cause some devices to produce a “Recommended Replacement Time” (first warning that the battery is low) earlier than expected. Some devices may progress from “Recommended Replacement Time” to full battery depletion within as little as one day.
Feature | EP Lab

April 12, 2021 — Medtronic is recalling some of its implantable cardioverter defibrillators (ICD) and cardiac ...

Home April 12, 2021
Home
News | EP Lab

April 2, 2021 — Today, the American College of Cardiology (ACC) launched the Electrophysiology (EP) Device Implant ...

Home April 02, 2021
Home
Integrating data from an array of implantable EP devices from different vendors can be difficult or require disconnected silos of data for different vendors. One solution that was recently introduced to integrate data from various vendors is the Optimize EP software, which allows viewing data from all device vendors in one platform to streamline workflows.
Feature | EP Lab | By Maninder Bedi, M.D.

A few weeks ago, a patient of mine experienced a cardiac event — his heart stopped. Completely. However, his implantable ...

Home March 17, 2021
Home
News | Cardiac Resynchronization Therapy Devices (CRT)

March 3, 2021 — Medtronic announced new results from the landmark REVERSE trial, evaluating outcomes of cardiac ...

Home March 03, 2021
Home
News | Implantable Cardioverter Defibrillator (ICD)

January 8, 2020 — A new study published this week in HeartRhythm, the journal of the Heart Rhythm Society (HRS), found ...

Home January 08, 2021
Home
Subscribe Now